POZZI MARIA ROSA

Pubblicazioni

  • Binda, V., Trezzi, B., Del Papa, N., Beretta, L., Frontini, G., Porata, G., et al. (2020). Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient). JN. JOURNAL OF NEPHROLOGY, 1-7. Dettaglio
  • Squillace, N., Pozzi, M., Gustinetti, G., Ricci, E., Capici, S., Columpsi, P., et al. (2020). Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment?. CLINICAL INFECTIOUS DISEASES. Dettaglio
  • Sinico, R., Sala, F., Pozzi, M., Fabbrini, P., & Pieruzzi, F. (2019). Microscopic Polyangiitis. In Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (pp. 131-144). Springer. Dettaglio
  • Cavagna, L., Trallero-Araguás, E., Meloni, F., Cavazzana, I., Rojas-Serrano, J., Feist, E., et al. (2019). Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. JOURNAL OF CLINICAL MEDICINE, 8(11), 2013. Dettaglio
  • Biffi, A., Dei, G., De Giacomi, F., Stainer, A., Parma, L., Pozzi, M., et al. (2018). Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view?. MONALDI ARCHIVES FOR CHEST DISEASE, 88(3), 16-21. Dettaglio